ASSESSING TREATMENT BENEFIT IN IMMUNO-ONCOLOGY
Publié le
This webinar was presented by Laurence Collette, MSc, PhD, Principal Statistician, Consulting Services at IDDI at the 5th Annual Next…
Publié le
This webinar was presented by Laurence Collette, MSc, PhD, Principal Statistician, Consulting Services at IDDI at the 5th Annual Next…
Publié le
Demystifying different types of Bayesian and frequentist designs that may be used for first-in-human or other types of phase I…
Publié le
Using the promising-zone approach can salvage an underpowered trial. Sample size Re-estimation (SSRE) is a relatively new concept, but, thanks…
Publié le
Vaiva Deltuvaite-Thomas, Research Statistician, IDDI and Prof. Tomasz Burzykowski, VP Research IDDI have just published an article on operational characteristics…
Publié le
Learn on pragmatic randomized clinical trials and real-world evidence KEY TAKEWAYS Patient access to evidence-based innovations can be accelerated if…
Publié le
Estimands Framework: Ensuring alignment between the key scientific question of interest, analysis and interpretation during clinical trial design. The estimands…
Publié le
At IDDI, statistical methodology is at the heart of every clinical study, driving study design, protocol development, clinical data collection,…
Publié le
Clinical Data Quality First! Your Trusted Partner Delivering Biostatistical and Clinical Data Science services since 1991 METHODOLOGICAL EXCELLENCE +…
Publié le
IDDI selected by a Sponsor as the full biometric partner including eClinical tools (EDC & RTSM), data collection, data cleaning…
Publié le
LEARN ON SAMPLE-SIZE RE-ESTIMATION, CONDITIONAL POWER AND THE PROMISING-ZONE METHOD. In this webinar, we will play the part of a sponsor consulting…